Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study - Université Sorbonne Paris Nord Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Medicine Année : 2021

Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study

Mark Olfson
  • Fonction : Auteur
  • PersonId : 1122538
Cédric Lemogne
  • Fonction : Auteur
  • PersonId : 1107269
Alexandre Gramfort
Pedro de La Muela
  • Fonction : Auteur
Anita Burgun
  • Fonction : Auteur
  • PersonId : 1005795

Résumé

Background: Based on its antiviral activity, anti-inflammatory properties, and functional inhibition effects on the acid sphingomyelinase/ceramide system (FIASMA), we sought to examine the potential usefulness of the H1 antihistamine hydroxyzine in patients hospitalized for COVID-19. (2) Methods: In a multicenter observational study, we included 15,103 adults hospitalized for COVID-19, of which 164 (1.1%) received hydroxyzine within the first 48 h of hospitalization, administered orally at a median daily dose of 25.0 mg (SD = 29.5). We compared mortality rates between patients who received hydroxyzine at hospital admission and those who did not, using a multivariable logistic regression model adjusting for patients’ characteristics, medical conditions, and use of other medications. (3) Results: This analysis showed a significant association between hydroxyzine use and reduced mortality (AOR, 0.51; 95%CI, 0.29–0.88, p = 0.016). This association was similar in multiple sensitivity analyses. (4) Conclusions: In this retrospective observational multicenter study, the use of the FIASMA hydroxyzine was associated with reduced mortality in patients hospitalized for COVID-19. Double-blind placebo-controlled randomized clinical trials of hydroxyzine for COVID-19 are needed to confirm these results, as are studies to examine the potential usefulness of this medication for outpatients and as post-exposure prophylaxis for individuals at high risk for severe COVID-19.
Fichier principal
Vignette du fichier
jcm-10-05891.pdf (1.61 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03519439 , version 1 (10-01-2022)

Identifiants

Citer

Marina Sánchez-Rico, Frédéric Limosin, Raphaël Vernet, Nathanaël Beeker, Antoine Neuraz, et al.. Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study. Journal of Clinical Medicine, 2021, 10 (24), pp.5891. ⟨10.3390/jcm10245891⟩. ⟨hal-03519439⟩
136 Consultations
72 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More